№ files_lp_4_process_3_095594
File format: docx
Character count: 27578
File size: 380 KB
This document outlines the provision of Emergency Hormonal Contraception (EHC) through community pharmacies in Lancashire, focusing on the supply of Levonorgestrel, the training of pharmacists, and related sexual health services.
Year:
2023
Region / City:
Lancashire
Theme:
Emergency Hormonal Contraception, Sexual Health
Document Type:
Service Specification
Organization:
Lancashire County Council
Author:
Marie Demaine
Target Audience:
Community Pharmacists, Health Care Professionals, Service Users
Period of Validity:
1st April 2023 – 31st March 2024
Approval Date:
2023-03-31
Modification Date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
England
Topic:
Emergency contraception
Document type:
Patient Group Direction (PGD)
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target audience:
Pharmacists, Pharmacy Technicians
Effective period:
June 2025 - February 2026
Approval date:
November 2022
Review date:
September 2025
Expiry date:
February 28, 2026
Year:
2020
Region / City:
Zhejiang Province, China
Field:
Gynecology
Document Type:
Case Report
Organization / Institution:
Zhejiang University School of Medicine, Women’s Hospital
Authors:
Zhou Y, Zheng-Yun Chen, Xin-Mei Zhang
Target Audience:
Medical professionals, researchers in gynecology
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Date received:
September 2, 2019
Date revised:
November 28, 2019
Date accepted:
December 13, 2019
Date published online:
January 6, 2020
Keywords:
Cystic adenomyosis, Dysmenorrhea, Levonorgestrel containing intrauterine device, Myomectomy, Case report
URL:
https://www.wjgnet.com/2307-8960/full/v8/i1/188.htm
DOI:
https://dx.doi.org/10.12998/wjcc.v8.i1.188
Context:
This is a medical case report detailing a rare instance of giant exophytic cystic adenomyosis with a levonorgestrel-containing intrauterine device out of the uterine cavity following uterine myomectomy.
Year:
2025
Region / City:
England
Topic:
Emergency contraception, NHS Pharmacy Contraception Service
Document Type:
Patient Group Direction
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target Audience:
Community Pharmacists, Pharmacy Technicians
Effective Date:
29 October 2025
Review Date:
September 2028
Expiry Date:
28 February 2029
Approval Date:
November 2022
Document Status:
Draft
Document Version:
1.0
Change History:
Version 1.0 approved on 20 June 2025
Clinical Condition:
Unprotected sexual intercourse, contraceptive failure
Criteria for Inclusion:
Emergency contraception within 96 hours post-UPS, vomiting after EC
Criteria for Exclusion:
Age under 16, pregnancy, recent childbirth or miscarriage
Cautions:
Fraser guidelines for underage assessments, safeguarding protocols
Context:
A PGD outlining the conditions and procedures for emergency contraception administration by authorized pharmacists and technicians in NHS pharmacies in England.
Version:
3.1
Date:
January 2026
Location/Service/Organisation:
[location/service/organisation]
PGD Development Group:
Reproductive Health PGDs Short Life Working Group
Reviewed by:
College of Sexual and Reproductive Health (CoSRH)
Date Template Comes into Effect:
1st April 2026
Review Date:
1st September 2028
Expiry Date:
31st March 2029
Year:
2023
Region / city:
USA, UK, Canada, Switzerland, Italy
Topic:
Endocrinology, Biomineralisation, Bone Health
Document Type:
Review Article
Institution:
University of Connecticut, University of Southampton, Memorial University of Newfoundland, Massachusetts General Hospital, Geneva University Hospitals, University of Florence, Mayo Clinic, University of Oxford
Author:
Andrew Arnold, Elaine Dennison, Christopher S. Kovacs, Michael Mannstadt, René Rizzoli, Maria Luisa Brandi, Bart Clarke, Rajesh V. Thakker
Target Audience:
Researchers, Medical Professionals, Endocrinologists
Period of Activity:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Contextual Description:
Review article on the hormonal regulation of biomineralisation, focusing on physiological and pathological processes, and their impact on skeletal health and mineral metabolism.
Year:
2010
Region / City:
Boston, MA
Theme:
Reproductive Health
Document Type:
Protocol
Institution:
Harvard Medical School
Author:
Unknown
Target Audience:
Female participants in NHS II aged 25-42 in 1989
Period of Action:
Not specified
Approval Date:
February 26, 2010
Modification Date:
Not specified
Note:
Year
Theme:
Emergency Hormonal Contraception
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
Pharmacy
Target Audience:
Pharmacists, Healthcare Professionals
Guidance:
The Pharmacy First Service for Emergency Hormonal Contraception (EHC)
Purpose:
To describe the process for implementing the Pharmacy First Service for Emergency Hormonal Contraception
Scope:
Provision of Emergency Hormonal Contraception to patients aged 13 and over by registered pharmacists
Document Type:
Educational text
Subject:
Female reproductive system anatomy and physiology
Scope:
Structure and function of reproductive organs
Primary Organs:
Ovaries
Secondary Organs:
Fallopian tubes, uterus, vagina, mammary glands, external genitalia
Physiological Processes:
Ovulation, fertilization, menstruation, ovarian cycle, uterine cycle, menopause
Hormones Mentioned:
Follicle-stimulating hormone, luteinizing hormone, estrogen, progesterone, prolactin, oxytocin, gonadotropin-releasing hormone
Anatomical Structures:
Ovarian follicles, corpus luteum, endometrium, cervix, infundibulum, fimbriae, placenta
Biological Focus:
Gamete production, hormonal regulation, fetal development, lactation
Target Audience:
Students of human biology or anatomy
Language:
English
Note:
Year
Document Type:
Medical claim form
Organization:
PHARMACY FIRST
Target Audience:
Pharmacists
Patient Age Groups:
13, 14, 15, 16 or >16
Medications Provided:
UPA-EC, LNG-EC, Desogestrel x 3 months bridging POP
Referral Sources:
GP, OOH, GUM, SH Clinic, Gateway
Consultation Outcomes:
EHC, POP
Consultation Fees:
£25, £15
Note:
Year
Year:
2023
Region / City:
Scotland
Topic:
Emergency Contraception, Bridging Contraception, Hormonal Contraception
Document Type:
Guidance
Author:
Faculty of Sexual and Reproductive Healthcare
Target Audience:
Community pharmacists, healthcare professionals
Period of validity:
2023-2024
Approval Date:
March 2017, amended July 2023
Date of Changes:
July 2023
Institution:
NHS Scotland
Healthcare Service:
Emergency Contraception, Bridging Contraception
Sexual Health:
Contraception, Pregnancy prevention
Eligibility:
Patients registered with a GP in Scotland, NHS Pharmacy First Scotland users
Conditions:
UKMEC categories, BMI considerations
Guidance:
Clinical, procedural recommendations
Service Specification No.:
Lot 6
Service:
Provision of Oral Emergency Contraception Services
Authority Lead:
Bernie Brown, Public Health, Derby City Council
Organisation:
Derby City Council
Period:
1 April 2022 – 31 March 2027 (with optional 1+1 year extensions)
Supporting Documentation:
Appendix A Care Pathway; Appendix B Patient Record – hard copy; Appendix C Patient Group Direction (PGD)
Geographical Area:
Derby City
Target Group:
Young women under 25 years of age
Clinical Focus:
Oral Emergency Contraception (Levonorgestrel), Ulipristal Acetate, Cu-IUD, Sexual Health, STI Prevention
Service Setting:
Primary Care
Related Services:
Integrated Sexual Health Service (ISHS); Derbyshire Community Health Services (DCHS)
Policy Framework:
Framework for Sexual Health Improvement in England; Public Health Outcomes Framework
Year:
2023
Country:
Scotland
Region:
Scotland
Subject:
Emergency contraception and bridging contraception
Document type:
Professional guidance
Issuing body:
NHS Scotland
Associated organization:
NHS 24
Note:
Associated organization
Faculty of Sexual and Reproductive Healthcare
Target audience:
Community pharmacists
Medicines referenced:
Ulipristal 30mg (EllaOne®), levonorgestrel, desogestrel
Legal framework:
Patient Group Directions (PGDs)
Geographical applicability:
Scotland
Amendment date:
July 2023
Year:
2025
Region / City:
England
Topic:
Emergency contraception
Document type:
Patient Group Direction (PGD)
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target audience:
Pharmacists, Pharmacy Technicians
Effective period:
June 2025 - February 2026
Approval date:
November 2022
Review date:
September 2025
Expiry date:
February 28, 2026
Year:
2025
Region / city:
United States
Topic:
Emergency Contraception
Document Type:
Clinical Practice Standard
Agency / Organization:
(insert AGENCY name)
Author:
(insert AGENCY name)
Target Audience:
Healthcare providers (MDs, NPs, PAs, DOs, NDs, RNs)
Effective Date:
January 2019
Revised Date:
January 2021, October 2022, January 2025
References:
U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC), U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR), Contraceptive Technology, 21st Ed
Date of Approval:
Not specified
Date of Changes:
October 2022, January 2025
Year:
2025
Region / City:
England
Topic:
Emergency contraception, NHS Pharmacy Contraception Service
Document Type:
Patient Group Direction
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target Audience:
Community Pharmacists, Pharmacy Technicians
Effective Date:
29 October 2025
Review Date:
September 2028
Expiry Date:
28 February 2029
Approval Date:
November 2022
Document Status:
Draft
Document Version:
1.0
Change History:
Version 1.0 approved on 20 June 2025
Clinical Condition:
Unprotected sexual intercourse, contraceptive failure
Criteria for Inclusion:
Emergency contraception within 96 hours post-UPS, vomiting after EC
Criteria for Exclusion:
Age under 16, pregnancy, recent childbirth or miscarriage
Cautions:
Fraser guidelines for underage assessments, safeguarding protocols
Context:
A PGD outlining the conditions and procedures for emergency contraception administration by authorized pharmacists and technicians in NHS pharmacies in England.
Type of document:
Survey questionnaire
Target population:
Fathers of a new baby
Subject:
Zika virus, pregnancy, mosquito prevention, contraception, paternal involvement
Geographic reference:
Puerto Rico
Administering authority:
CDC/ATSDR Information Collection Review Office
Related program:
PRAMS (Pregnancy Risk Assessment Monitoring System)
Estimated completion time:
15 minutes
Data collection context:
Hospital-based survey
Regulatory reference:
OMB control number requirement
Topics covered:
Zika virus awareness, sexual transmission, microcephaly, mosquito bite prevention, condom use, contraception decision-making, prenatal care participation, employment information
Note:
Year
Theme:
Emergency Hormonal Contraception
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
Pharmacy
Target Audience:
Pharmacists, Healthcare Professionals
Guidance:
The Pharmacy First Service for Emergency Hormonal Contraception (EHC)
Purpose:
To describe the process for implementing the Pharmacy First Service for Emergency Hormonal Contraception
Scope:
Provision of Emergency Hormonal Contraception to patients aged 13 and over by registered pharmacists